Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo in Generalized Anxiety Disorder

Completed · Phase 3

Conditions studied: Generalized Anxiety Disorder

In brief

The purpose of this study is to demonstrate that quetiapine SR (SEROQUEL®) is efficacious and safe in the acute treatment of patients with Generalized Anxiety Disorder. PLEASE NOTE: Seroquel SR and Seroquel XR refer to the same formulation. The SR designation was changed to XR after consultation with FDA.

Key facts

Study ID

NCT00329264

Run by

AstraZeneca

People needed

876

Starts

2006-04-01

Expected to finish

2007-08-01

Last updated by the study team

2009-03-25

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patient has a documented clinical diagnosis of Generalized Anxiety Disorder.
• Be able to understand and comply with the requirements of the study.
• Able to understand and provide written informed consent

You may not qualify if…

• Patients (female) must not be pregnant or lactating
• Current or past diagnosis of stroke or transient ischemic attack (TIA).

Where it is running

• Research Site — Little Rock, Arkansas, United States
• Research Site — Encino, California, United States
• Research Site — Newport Beach, California, United States
• Research Site — Oceanside, California, United States
• Research Site — Redlands, California, United States
• Research Site — Santa Ana, California, United States
• Research Site — Denver, Colorado, United States
• Research Site — Norwich, Connecticut, United States
• Research Site — Washington D.C., District of Columbia, United States
• Research Site — Fort Walton Beach, Florida, United States
• Research Site — Gainsville, Florida, United States
• Research Site — Hialeah, Florida, United States
• Research Site — Jacksonville, Florida, United States
• Research Site — Miami, Florida, United States
• Research Site — Orlando, Florida, United States
• Research Site — Tampa, Florida, United States
• Research Site — Winter Park, Florida, United States
• Research Site — Atlanta, Georgia, United States
• Research Site — Smyrna, Georgia, United States
• Research Site — Eagle, Idaho, United States
• Research Site — Chicago, Illinois, United States
• Research Site — Oak Brook, Illinois, United States
• Research Site — Indianapolis, Indiana, United States
• Research Site — Topeka, Kansas, United States
• Research Site — Springdale, Arizona, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.